Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation

PURPOSE: Diabetic retinopathy (DR) is associated with microglial activation and increased levels of inflammatory cytokines. Genistein, a tyrosine kinase inhibitor, has been shown to possess anti-inflammatory potential that so far untested in animal models of diabetes. The aims of this study are to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Ahmed S., El-Shishtawy, Mamdouh M., Peña, Alejandro, Liou, Gregory I.
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965567/
https://www.ncbi.nlm.nih.gov/pubmed/21042558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965567/
https://www.ncbi.nlm.nih.gov/pubmed/21042558

Ejemplares similares